Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2007 by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier:
NCT00498082
First received: July 6, 2007
Last updated: September 5, 2007
Last verified: September 2007
  Purpose

EsophyX is a promising endoscopic treatment for gastro-esophageal reflux disease. It is not known whether there are some pre- or per-operative anatomic or pathophysiological findings which may influence outcome.

The aim of this trial is to study a series of parameters acquired during the pre-therapeutic work-up or during the procedure and their influence on the outcome of the procedure.


Condition
Gastroesophageal Reflux Disease

Study Type: Observational
Study Design: Time Perspective: Longitudinal
Official Title: Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

Resource links provided by NLM:


Further study details as provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:

Study Start Date: September 2007
Estimated Study Completion Date: September 2008
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients being considered for EsophyX treatment of GERD
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00498082

Contacts
Contact: Hubert Piessevaux, MD, PhD + 32 2 764 28 34 piessevaux@gaen.ucl.ac.be

Locations
Belgium
Cliniques universitaires St-Luc Recruiting
Brussels, Belgium, 1200
Principal Investigator: Hubert Piessevaux, MD, PhD         
Sponsors and Collaborators
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigators
Principal Investigator: Hubert Piessevaux, MD, PhD Cliniques universitaires St-Luc
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00498082     History of Changes
Other Study ID Numbers: UCL-STLUC-GAS-01
Study First Received: July 6, 2007
Last Updated: September 5, 2007
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Gastroesophageal Reflux
Esophageal Motility Disorders
Deglutition Disorders
Esophageal Diseases
Gastrointestinal Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on September 30, 2014